ALT-200

N/A

Report date: 2025/01/26 18:41:32

Base Information

Drug NameALT-200
Drug Alias Nameantinicotinamide phosphoribosyltransferase humanized monoclonal antibody (Aqualung Therapeutics)ALT-200
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionNicotinamide phosphoribosyltransferase inhibitors
TargetsNicotinamide phosphoribosyltransferase
Therapy Area/IndicationsFibrosisLung InjuryPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAqualung Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesAqualung Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsFibrosisLung InjuryPneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A